| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.3 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.086 | 0.06 |